Literature DB >> 8038350

Activity of metronidazole, azithromycin and three benzimidazoles on Giardia lamblia growth and attachment to a human intestinal cell line.

P H Katelaris1, A Naeem, M J Farthing.   

Abstract

BACKGROUND: Attachment of Giardia lamblia trophozoites to enterocytes is essential for colonization of the small intestine and is considered a prerequisite for Giardia-induced enterocyte damage. Inhibition of attachment may therefore have therapeutic potential.
METHODS: Enterocyte-like differentiated Caco-2 cells were used as a biologically appropriate attachment surface to determine the effect of three benzimidazole compounds (albendazole, mebendazole and thiabendazole), azithromycin and metronidazole on Giardia attachment. The results were compared with the ability for each drug to inhibit Giardia growth, measured using [3H]-thymidine uptake.
RESULTS: The benzimidazoles inhibited Giardia attachment at much lower concentrations than did metronidazole. However, metronidazole was a much more potent inhibitor of growth than any of the benzimidazoles. Azithromycin did not significantly impair Giardia attachment or growth. The benzimidazoles decrease attachment but are less giardiacidal than metronidazole.
CONCLUSION: This model appears useful for testing potential antigiardial compounds and investigating mechanisms of drug action.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8038350     DOI: 10.1111/j.1365-2036.1994.tb00277.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  Lactobacillus johnsonii La1 antagonizes Giardia intestinalis in vivo.

Authors:  Martín A Humen; Graciela L De Antoni; Jalil Benyacoub; María E Costas; Marta I Cardozo; Leonora Kozubsky; Kim-Yen Saudan; Angele Boenzli-Bruand; Stephanie Blum; Eduardo J Schiffrin; Pablo F Pérez
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

2.  Inhibition of Giardia intestinalis by extracellular factors from Lactobacilli: an in vitro study.

Authors:  P F Pérez; J Minnaard; M Rouvet; C Knabenhans; D Brassart; G L De Antoni; E J Schiffrin
Journal:  Appl Environ Microbiol       Date:  2001-11       Impact factor: 4.792

3.  Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children.

Authors:  Roberto Canete; Angel A Escobedo; Maria E Gonzalez; Pedro Almirall
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

4.  Release of metabolic enzymes by Giardia in response to interaction with intestinal epithelial cells.

Authors:  Emma Ringqvist; J E Daniel Palm; Hanna Skarin; Adrian B Hehl; Malin Weiland; Barbara J Davids; David S Reiner; William J Griffiths; Lars Eckmann; Frances D Gillin; Staffan G Svärd
Journal:  Mol Biochem Parasitol       Date:  2008-02-15       Impact factor: 1.759

5.  Comparative therapeutic effect of probiotic Lactobacillus casei alone and in conjunction with antiprotozoal drugs in murine giardiasis.

Authors:  Geeta Shukla; Hemjeet Kaur; Lalita Sharma
Journal:  Parasitol Res       Date:  2013-04-05       Impact factor: 2.289

6.  A data-driven predictive approach for drug delivery using machine learning techniques.

Authors:  Yuanyuan Li; Scott C Lenaghan; Mingjun Zhang
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.